BSECompany Update1d ago · 17 Nov 2026, 08:04 pm
Audio Recording of the Analysts/Investors Earnings Call - Orchid Pharma Limited ('the Company')
Orchid Pharma Ltd · 524372
✦ AI SummaryResults
Orchid Pharma Ltd has uploaded the audio recording of its Analysts/Investors Earnings Call on its website, discussing unaudited limited reviewed financial results for Q2 FY 2026-27.
Analysis Scores
Earnings Impact8/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk3/10
Liquidity Impact9/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Attachments (1)
📄pdf
Download →
a5da1528-d393-41c4-ab34-555c9b402699.pdf
View document text
November 17, 2026
National Stock Exchange of India Limited, BSE Limited
Exchange Plaza, Bandra Kurla Complex Phiroze Jeejeebhoy Towers,
Bandra (E), Mumbai-400051 Dalal Street, Fort, Mumbai-400001
Symbol: ORCHPHARMA Scrip Code: 524372
Ref: (i) Regulation 30 of Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015
(ii)SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-
POD2/I/3762/2026 dated January 30, 2026
Sub: Audio Recording of the Analysts/Investors Earnings Call - Orchid Pharma
Limited (“the Company”)
Dear Sir/Madam,
With reference to the above captioned subject and pursuant to Regulation 30, Sub-para
15 of Para A Part A of Schedule III of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015, as amended, read with
SEBI Circular no. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30,
2026 and in continuation to earlier intimations dated November 12 & 16, 2026 for
Analysts/ Investors Earnings Call, we would like to inform you that the Audio Recording
of the Analysts/Investors Earnings Call held today i.e. November 17, 2026 at 04:30 P.M.
(IST) to discuss the Unaudited Limited Reviewed Financial Results (Standalone and
Consolidated) for the Quarter- II of Financial Year 2026-27, ended on September 30,
2026, has been uploaded on the website of the Company. Please find below the link to
the Audio Recording of the same:
Link:
https://orchid-pharma.b-cdn.net/audios/10049646.mp3
This is to confirm that the Analysts/Investors Earnings call was held through Audio
Conference call and no Video Recording is available for same.
You are requested to take the above on your record.
Thanking You,
For Orchid Pharma Limited
Kapil Dayya
Company Secretary & Compliance Officer
Mem. No.: F10698